You just read:

Eiger BioPharmaceuticals Announces Phase 2 ULTRA Results of Ubenimex in Lower Leg Lymphedema: Study Did Not Meet Primary or Secondary Endpoint

News provided by

Eiger BioPharmaceuticals, Inc.

Oct 16, 2018, 16:05 ET